Tilray Launches CBD Lifestyle Brand, Pollen, on Amazon UK
LONDON – Tilray Brands, Inc. (NASDAQ | TSX: TLRY), a global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, announced the launch of POLLEN, a CBD lifestyle brand with a new approach to wellness, on Amazon UK.
Designed to help uncomplicate wellness routines and elevate the CBD experience for consumers, POLLEN offers a unique product mix of tasty CBD gummies and drink drops in three signature lines; ‘Powerbank’ to promote a natural energy boost, ‘No Pressure’ to soften the pressure of everyday stresses and restore your body’s natural bounce, and ‘Soothe You’ for mind and body balance. Each POLLEN product is formulated with CBD and a range of flavorful and vegan-friendly ingredients that simply taste and feel good.
Powerbank – Developed to give you that ‘full tank’ feeling. Powerbank CBD Gummies are a combination of lemon, orange and cacao. Powerbank CBD drink drops include citrus and warm tones of lemon, orange, and coffee to promote a natural energy boost.
No Pressure – Created for those seeking to relax, No Pressure Gummies feature grapefruit, turmeric + cayenne while the No Pressure Drink Drops are packed with a punch of blackcurrant.
Soothe You – All about finding that sense of serenity and balance. Soothe You CBD Gummies include a relaxing blend of chamomile, honey, and cherry. The CBD Drink Drops are a breath of fresh air with tasty hints of grapefruit and raspberry.
POLLEN CBD Gummies offer 300mg of CBD per pack and are independently tested for an accurate dosage every time. All POLLEN products are plant-based, pesticide-free, vegan-friendly, and produced with an award-winning team delivering first-to-market category innovation.
POLLEN’s ‘Powerbank’, ‘Soothe You’ and ‘No Pressure’ Vegan CBD Gummies and Drink Drops are now available only on Amazon UK. Be on the lookout for a wider release at local retailers across the UK and online.
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations. Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Tilray or that the Tilray deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Tilray does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events
(This information is primarily sourced from Tilray Brands, Inc. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Arizona Legislature Seeks to Slash Medical Cannabis Card Prices Amid Declining Sales and Patient Numbers
PHOENIX-- In an effort to revive Arizona's struggling medical cannabis market, lawmakers are pushing forward a bill aimed at reducing the cost of medical cannabis cards. Senate Bill 1466, which received approval from the state ...
New York Regulators Pave the Way for Cannabis Farmers’ Markets Amid Supply Glut
NEW YORK-- In a bid to address the surplus of cannabis products and support local cultivators, regulators in New York have announced plans to introduce cannabis farmers' markets this summer. The move, spearheaded by the ...
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...